Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Pension (2012 - 2014)

BioLineRx (BLRX) posted Pension of -$42000.0 for Q4 2014, down 202.44% on a QoQ basis from $41000.0 in Q3 2014, and down 2200.0% year-over-year from $2000.0 in Q4 2013.

BioLineRx (BLRX) has 3 years of Pension data on file, last reported at -$42000.0 in Q4 2014.

  • In Q4 2014, Pension fell 2200.0% year-over-year to -$42000.0; the TTM figure through Dec 2014 stood at -$42000.0 (down 2200.0% YoY), while the FY2014 annual figure was -$42000.0, down 2200.0% from the prior year.
  • Pension eased to -$42000.0 in Q4 2014, from $41000.0 in the prior quarter.
  • Across five years, Pension topped out at $44000.0 in Q1 2014 and bottomed at -$42000.0 in Q4 2014.
  • A 3-year average of $27444.4 and a median of $40000.0 in 2013 frame the typical range for Pension.
  • The widest YoY moves for Pension: up 12.82% in 2014, down 2200.0% in 2014.
  • Year by year, Pension stood at $38000.0 in 2012, then slumped by 94.74% to $2000.0 in 2013, then sank by 2200.0% to -$42000.0 in 2014.
  • The last three Pension figures came in at -$42000.0 (Q4 2014), $41000.0 (Q3 2014), and $44000.0 (Q2 2014), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 BioLineRx 9.32 Bn 9.30 Bn 154,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2014 -42,000.00
Sep 30, 2014 41,000.00
Jun 30, 2014 44,000.00
Mar 31, 2014 44,000.00
Dec 31, 2013 2,000.00
Sep 30, 2013 41,000.00
Jun 30, 2013 40,000.00
Mar 31, 2013 39,000.00
Dec 31, 2012 38,000.00